Cryo Cell International (CCEL) Total Non-Current Liabilities (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $80.3 million as the latest value for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 3.14% to $80.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was $80.3 million, a 3.14% increase, with the full-year FY2025 number at $80.3 million, up 3.14% from a year prior.
- Total Non-Current Liabilities was $80.3 million for Q4 2025 at Cryo Cell International, up from $18.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $105.3 million in Q1 2021 to a low of $15.7 million in Q2 2022.
- A 5-year average of $48.1 million and a median of $51.9 million in 2021 define the central range for Total Non-Current Liabilities.
- Peak YoY movement for Total Non-Current Liabilities: skyrocketed 9667.19% in 2021, then tumbled 74.53% in 2025.
- Cryo Cell International's Total Non-Current Liabilities stood at $21.1 million in 2021, then decreased by 7.56% to $19.5 million in 2022, then skyrocketed by 270.65% to $72.2 million in 2023, then grew by 7.81% to $77.8 million in 2024, then rose by 3.14% to $80.3 million in 2025.
- Per Business Quant, the three most recent readings for CCEL's Total Non-Current Liabilities are $80.3 million (Q4 2025), $18.5 million (Q3 2025), and $21.8 million (Q2 2025).